ContextVision AB: ContextVision Files Patent on New Technology

Regulatory News:

ContextVision (OSE:COV), a leading provider of medical image enhancement software, filed a patent application last week on a new technology that serves to optimize image quality within multiple medical technologies.

The technology, which was developed within the company, combines a substantial library of algorithms for feature extraction and sophisticated artificial intelligence to translate the clinical evaluation of medical images into a quality metrics. An image´s quality metric may then be used to evaluate and enhance image quality automatically, without direct involvement of a clinical expert.

- "The new technology has provided us with a completely new platform for product development which we call the ´Virtual Expert´. This will be used as a basis for many of our future products”, says Anita Tollstadius, CEO, ContextVision.

Being able to automatically evaluate image quality allows adjustment of medical images in order to further improve the diagnostic value of medical imaging.

- "The technology broadens our capabilities within image analysis and our artificial intelligence will allow for automation of new functions,” says Tollstadius.

About ContextVision

ContextVision is a leading provider of image enhancement software to the global medical imaging industry since 1983, with the versatile GOP® technology at its core. We play a key role in helping manufacturers by offering clinicians unparalleled diagnostic image quality, ultimately providing patients with better care. ContextVision continues to offer the latest software and expertise within ultrasound, x-ray, magnetic resonance imaging, mammography, fluoroscopy and computed tomography. Our groundbreaking technology and lengthy expertise have granted us a pioneer position within 2D/3D/4D image enhancement across multiple modalities. For more information, please visit www.contextvision.com.

This information was brought to you by Cision http://news.cision.com